SANOFI.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Stats
Tagesvolumen	8 340.00
Durchschnittsvolumen	18 653.00
Marktkapitalisierung	190.55B
EPS	INR0 ( 2024-02-23 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-10
Last Dividend	INR183.00 ( 2023-04-28 )
Next Dividend	INR0 ( N/A )
P/E	31.61
ATR14	INR5.33 (0.06%)

Volumen Korrelation

Lang: 0.18 (neutral)

Kurz: 0.87 (strong)

Signal:(49.238) Same movement expected

Sanofi India Limited Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Sanofi India Limited Korrelation - Währung/Rohstoff

0.41
( neutral )

0.50
( neutral )

0.14
( neutral )

0.32
( neutral )

-0.22
( neutral )

-0.50
( weak negative )

Sanofi India Limited Finanzdaten

Annual	2023
Umsatz:	INR28.51B
Bruttogewinn:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2023
Umsatz:	INR28.51B
Bruttogewinn:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2022
Umsatz:	INR27.70B
Bruttogewinn:	INR15.81B (57.06 %)
EPS:	INR269.47

FY	2021
Umsatz:	INR29.57B
Bruttogewinn:	INR16.50B (55.80 %)
EPS:	INR410.06

Financial Reports:

No articles found.

Sanofi India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR193.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR183.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sanofi India Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.09 - Stable (18.23%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR13.50	2003-05-30
Last Dividend	INR183.00	2023-04-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	39	--
Total Paid Out	INR1 983.50	--
Avg. Dividend % Per Year	2.98%	--
Score	4.36	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.09
Div. Directional Score	7.59	--

Next Divdend (Est)
(2024-10-07)

INR189.96 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR71.00	1.47%
2019	INR66.00	1.04%
2020	INR486.00	6.93%
2021	INR240.00	2.90%
2022	INR502.00	6.45%
2023	INR183.00	3.14%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SALASAR.NS	Dividend Junior	2023-09-15	Annually	8	1.41%
LUPIN.NS	Dividend Junior	2023-07-14	Annually	23	0.37%
GIPCL.NS	Dividend Junior	2023-09-08	Annually	21	2.50%
ASHIANA.NS	Dividend Junior	2023-09-21	Annually	14	0.37%
TIMETECHNO.NS	Dividend Junior	2023-09-18	Annually	17	0.93%
PARADEEP.NS	No Dividend Player	2023-09-18	Insufficient data to determine frequency	2	0.28%
IVC.NS	Dividend Knight	2023-08-17	Annually	23	5.55%
DALBHARAT.NS	Dividend Junior	2023-06-23	Annually	7	0.30%
SHRIPISTON.NS	Dividend Junior	2023-06-27	Semi-Annually	9	0.89%
MATRIMONY.NS	Dividend Junior	2023-08-03	Annually	7	0.41%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.211	1.500	5.77	8.66	[0 - 0.5]
returnOnAssetsTTM	0.352	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.645	1.500	3.95	5.92	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.860	0.800	9.65	7.72	[0.8 - 2.5]
cashRatioTTM	0.624	1.500	7.64	10.00	[0.2 - 2]
debtRatioTTM	0.0111	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	480.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
freeCashFlowPerShareTTM	25.53	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0187	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.287	1.000	6.27	6.27	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.09	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.663	0.800	2.25	1.799	[0.5 - 2]
Total Score				11.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.61	1.000	6.91	0	[1 - 100]
returnOnEquityTTM	0.645	2.50	6.11	5.92	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.53	2.00	1.490	10.00	[0 - 30]
dividendYielPercentageTTM	0.604	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.10	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0206	1.000	-1.984	0	[0.1 - 0.5]
Total Score				4.09

Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.